Cutter & CO Brokerage, Inc. Abbott Laboratories Transaction History

Cutter & CO Brokerage, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $5,741 - $6,409	57 Added 2.31%	2,524 $262,000
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $270,185 - $298,408	2,467 New	2,467 $280,000
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $248,107 - $302,551	-2,176 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $115 - $141	1 Added 0.05%	2,176 $306,000
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $116 - $129	1 Added 0.05%	2,175 $257,000
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $19,147 - $22,539	-181 Reduced 7.69%	2,174 $252,000
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $10,775 - $12,694	-99 Reduced 4.03%	2,355 $282,000
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $36,855 - $40,161	351 Added 16.69%	2,454 $269,000
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $192,718 - $234,042	2,103 New	2,103 $229,000
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $183,001 - $213,435	-2,511 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$66.22 - $80.06 $166,278 - $201,030	2,511 New	2,511 $201,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.